Skip to content
Checked.be
Complete company report
Generated 21-08-2026
Active BE 0732.982.379Public limited company

EXO Biologics

Boulevard de Patience et Beaujonc 3 ·4000 Liège, Belgium· 6 yrs active
Sector: Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied (72109)
Conclusion Checked

The computed 12-month bankruptcy probability of EXO Biologics is 0.7% (low). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 6 yrs
Board 5
Locations 1
Publications 10
Bankruptcy probability (12 mo) Checked model v1 · free
0.7% Low
0%0,5%1,5%4%10%≥25%
Young company +Lower-failure-rate sector −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview5 NBB filings
Financials being processed
NBB has 5 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 14-07-2025 2025-00267625
31-12-2023 volledig 16-07-2024 2024-00252966
31-12-2022 micro 20-07-2023 2023-00263764
31-12-2021 micro 06-10-2022 2022-20452448
31-12-2020 micro 29-07-2021 2021-43800348
Directors & mandates 5 directors
Current directors & mandates
  • NOSHAQ PARTNERSLegal entity
    Director· perm. rep.: Amel TOUNSI
    State Gazette act 24093411 (21-06-2024)
    Current
    07-02-2024 → present
    2 events
    • 07-02-2024 Resigned· Director
    • 07-02-2024 Appointed· Director
  • Biotech Management & ConsultingLegal entity
    Daily management· perm. rep.: Hugues Wallemacq
    State Gazette act 22151982 (27-12-2022)
    Current
    27-12-2022 → present
  • JURGA Marcin
    Director
    State Gazette act 21149918 (23-12-2021)
    Current
    29-09-2021 → present
  • Margarite LimitedLegal entity
    Director· perm. rep.: DALTON Colin Clive
    State Gazette act 21149918 (23-12-2021)
    Current
    29-09-2021 → present
  • NOSHAQLegal entity
    Director· perm. rep.: TOUNSI Amel
    State Gazette act 21149918 (23-12-2021)
    Current
    29-09-2021 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor 1 auditor
Statutory auditor IRE/IBR number Tenure
Baker Tilly Audit, Comptabilité, ConseilCurrent
Company auditor · represented by Christophe HABETS
 - 31-12-2025 → present
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109)
Legal form Public limited company(014)
Incorporation29-08-2019
StatusActive
Postal code4000
Connections & network 27 connected companies
Group structure
NOSHAQ
Sits on the board · 26 subsidiaries · 2 locations
Control→
Network connections
→
AMPACIMON
Shared corporate director
→
Another Sound
Shared corporate director
→
AQUATIC SCIENCE
Shared corporate director
→
Show 2 more network connections
BIO-SOURCING
Shared corporate director
→
Bridge2Health
Shared corporate director
→
20 further connected companies in this network. Available in Kantoor S. See plans →
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control 1 parties
Control over this companysits on this company's board1
NOSHAQ
26 subsidiaries · 2 locations
controls
EXO BiologicsBE 0732.982.379

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Establishment units 1 location
EXO BIOLOGICS
Boulevard de Patience et Beaujonc 3, 4000 LiègeVervaardiging van geneesmiddelen
since 20232.349.033.855
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62042B0366/00B003 Wallonia 1.9 ha - -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 15 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
23-01-2026
State Gazette act Capital & shares
v3.2
2025
14-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
20-12-2024
State Gazette act Minor change
Agm rules change · Frederik Vlaminck
13-09-2024
State Gazette act Capital & shares
v3.2
16-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
21-06-2024
State Gazette act Director changes
v3.2
04-03-2024
State Gazette act Director changes
v3.2
16-02-2024
State Gazette act Capital & shares
v3.2
2023
12-10-2023
State Gazette act Capital & shares
v3.2
20-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · micro
2022
27-12-2022
State Gazette act Director changes
v3.2
06-10-2022
NBB filing Annual accounts filed
fiscal year 2021 · micro
2021
23-12-2021
State Gazette act Director changes
v3.2
29-07-2021
NBB filing Annual accounts filed
fiscal year 2020 · micro
2019
02-09-2019
State Gazette act Incorporation
oprichting
Belgian State Gazette reading coverage 0 of 10 acts read

We know of 10 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 10 acts
Capital history · 4
23-01-2026
v3.2
13-09-2024
v3.2
16-02-2024
v3.2
12-10-2023
v3.2
All acts · 10 updated 7 months ago
2026
23-01-2026 Capital decrease of €2,061,102.26 to €5,120,717.88 Capital & shares
  • €7.181.820,14 → €5.120.717,88
  • 2 kapitaalbewegingen in deze akte
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2000000.0,
      "currency": "EUR",
      "after_eur": 7181820.14,
      "delta_eur": 2000000.0,
      "before_eur": 5181820.14,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-12-31",
      "evidence_quote": "augmenter le capital \u00E0 concurrence de deux millions (\u20AC 2.000.000,00) pour le porter de cinq millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 5.181.820,14) \u00E0 sept millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 7.181.820,14) par la cr\u00E9ation quatre mille six cent neuf (4.609) nouvelles Actions Classe A ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es ... en r\u00E9mun\u00E9ration de l\u2019apport, \u00E0 concurrence de deux millions (\u20AC 2.000.000,00), d\u2019une cr\u00E9ance qu\u2019il d\u00E9tient sur la soci\u00E9t\u00E9.",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_decrease",
      "amount": 2061102.26,
      "currency": "EUR",
      "after_eur": 5120717.88,
      "delta_eur": -2061102.26,
      "before_eur": 7181820.14,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-12-31",
      "evidence_quote": "r\u00E9duire le capital \u00E0 concurrence de deux millions soixante et un mille cent deux euros vingt-six cents (\u20AC 2.061.102,26) pour le ramener de sept millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 7.181.820,14) \u00E0 cinq millions cent vingt mille sept cent dix-sept euros quatre-vingt-huit cents (\u20AC 5.120.717,88) par apurement de la totalit\u00E9 des pertes subies au 31 d\u00E9cembre 2024 et sans r\u00E9duction du nombre d\u2019actions.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
2024
20-12-2024 Publication in the Belgian Official Gazette, Minor change Minor change·Frederik Vlaminck
Summary: Agm rules changeNotary: Frederik Vlaminck · Antwerpen
Technical details 
{
  "notary": {
    "name": "Frederik Vlaminck",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-12-20",
    "filing_date": "2024-12-18",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2024-12-12",
    "unanimous": null
  },
  "agm_change": {
    "new_schedule": null,
    "old_schedule": null,
    "effective_from_year": null,
    "rule_changes_summary": "Adaptation of article 5 of the statutes to the new capital situation, replacing the first sentence with a new clause defining the capital."
  },
  "detected_kind": "agm_rules_change",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO Biologics",
    "legal_form": "SA"
  },
  "accounts_deposit": {
    "filing_kind": null,
    "fiscal_year_end": "2023-12-31",
    "filing_reference": "*24453545*"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal du 12 d\u00E9cembre 2024",
    "procurations",
    "texte des statuts",
    "extrait"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}
13-09-2024 Capital increase of €691,666 to €10,314,687.90 Capital & shares
  • €9.623.021,90 → €10.314.687,90
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 691666.0,
      "currency": "EUR",
      "after_eur": 10314687.9,
      "delta_eur": 691666.0,
      "before_eur": 9623021.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-03",
      "evidence_quote": "augmenter le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de six cent nonante-et-un mille six cent soixante-six euros (\u20AC 691.666,00) pour le porter de neuf millions six cent vingt-trois mille vingt et un euros nonante cents (\u20AC 9.623.021,90) \u00E0 dix millions trois cent quatorze mille six cent quatre-vingt-sept euros nonante cents (\u20AC 10.314.687,90) par apport en num\u00E9raire",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
21-06-2024 1 director appointed, 1 resigning Director changes
  • Eric BRANDT, Bestuurder
  • Amel TOUNSI, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Amel TOUNSI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "Par un courrier du 6 f\u00E9vrier 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. EXO BIOLOGICS, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Eric BRANDT, avec effet au 7 f\u00E9vrier 2024"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric BRANDT",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "Par un courrier du 6 f\u00E9vrier 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. EXO BIOLOGICS, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Eric BRANDT, avec effet au 7 f\u00E9vrier 2024"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
04-03-2024 1 director appointed, 1 resigning Director changes
  • Yvan ABSIL, Bestuurder
  • Amel TOUNSI, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Amel TOUNSI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0732982379",
        "name": "NOSHAQ IMMO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Yvan ABSIL, avec effet au 7 f\u00E9vrier 2024"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yvan ABSIL",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0732982379",
        "name": "NOSHAQ IMMO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Yvan ABSIL, avec effet au 7 f\u00E9vrier 2024"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
16-02-2024 Capital increase of €2,627,152 to €7,248,021.90 Capital & shares
  • €4.620.869,90 → €7.248.021,90
  • 2 kapitaalbewegingen in deze akte
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2627152.0,
      "currency": "EUR",
      "after_eur": 7248021.9,
      "delta_eur": 2627152.0,
      "before_eur": 4620869.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-12-29",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de deux millions six cent vingt-sept mille cent cinquante-deux euros (\u20AC 2.627.152,00) pour le porter de quatre millions six cent vingt mille huit cent soixante-neuf euros nonante cents (\u20AC 4.620.869,90) \u00E0 sept millions deux cent quarante-huit mille vingt et un euros nonante cents (\u20AC 7.248.021,90) par la cr\u00E9ation de six mille cent septante-et-un (6.171) nouvelles Actions Classe C... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019\u00E9gard de la soci\u00E9t\u00E9 \u00E0 concurrence de deux millions six cent vingt-sept mille cent cinquante-deux euros (\u20AC 2.627.152,00) au total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 2375000.0,
      "currency": "EUR",
      "after_eur": 9623021.9,
      "delta_eur": 2375000.0,
      "before_eur": 7248021.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-12-29",
      "evidence_quote": "d\u2019augmenter le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de deux millions trois cent septante-cinq mille euros (\u20AC 2.375.000,00) pour le porter de sept millions deux cent quarante-huit mille vingt et un euros nonante cents (\u20AC 7.248.021,90) \u00E0 neuf millions six cent vingt-trois mille vingt et un euros nonante cents (\u20AC 9.623.021,90) par apport en num\u00E9raire et par la cr\u00E9ation de cinq mille cinq cents (5.500) actions... qui seront imm\u00E9diatement lib\u00E9r\u00E9es enti\u00E8rement",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
2023
12-10-2023 Capital increase of €5,000,000 to €5,600,000 Capital & shares
  • €600.000 → €5.600.000
  • 3 kapitaalbewegingen in deze akte
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 5000000,
      "currency": "EUR",
      "after_eur": 5600000,
      "delta_eur": 5000000,
      "before_eur": 600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de cinq millions (\u20AC 5.000.000,00) pour le porter de six cent mille (\u20AC 600.000,00) \u00E0 cinq millions six cent mille euros (\u20AC 5.600.000,00) par la cr\u00E9ation de seize mille deux cent quatorze (16.214) nouvelles actions ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019encontre de la soci\u00E9t\u00E9 \u00E0 concurrence de cinq millions (\u20AC 5.000.000,00) en total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 3000000,
      "currency": "EUR",
      "after_eur": 8600000,
      "delta_eur": 3000000,
      "before_eur": 5600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de trois millions (\u20AC 3.000.000,00) pour le porter de cinq millions six cent mille euros (\u20AC 5.600.000,00) \u00E0 huit millions six cent mille euros (\u20AC 8.600.000,00) par la cr\u00E9ation de huit mille quatre cent soixante-sept (8.467) nouvelles actions ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019encontre de la soci\u00E9t\u00E9 \u00E0 concurrence de trois millions (\u20AC 3.000.000,00) en total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_decrease",
      "amount": 3979130.1,
      "currency": "EUR",
      "after_eur": 4620869.9,
      "delta_eur": -3979130.1,
      "before_eur": 8600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "de r\u00E9duire le capital \u00E0 concurrence de trois millions neuf cent septante-neuf mille cent trente euros dix cents (\u20AC 3.979.130,10) pour le ramener de huit millions six cent mille euros (\u20AC 8.600.000,00) \u00E0 quatre millions six cent vingt mille huit cent soixante-neuf euros nonante cents (\u20AC 4.620.869,90) par apurement de la totalit\u00E9 des pertes subies au 31 d\u00E9cembre 2022",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
2022
27-12-2022 Hugues Wallemacq appointed as daily management Director changes
  • Hugues Wallemacq, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Hugues Wallemacq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0741644479",
        "name": "Biotech Management \u0026 Consulting SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Apr\u00E8s d\u00E9lib\u00E9ration, le Conseil d\u00E9cide \u00E0 l\u0027unanimit\u00E9 (i) de nommer la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u003C Biotech Management \u0026 Consulting \u003E, avec adresse \u00E0 4458 Fexhe-Slins, Rue Neuve 31, num\u00E9ro d\u0027entreprise 0741.644.479 (RPM Li\u00E8ge, division Li\u00E8ge), comme d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, qui sera rep"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
2021
23-12-2021 3 directors appointed Director changes
  • JURGA Marcin, Bestuurder
  • TOUNSI Amel, Bestuurder
  • DALTON Colin Clive, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "JURGA Marcin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nominer les personnes suivantes comme administrateur de la Soci\u00E9t\u00E9 jusque la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2026: -Monsieur JURGA Marcin, habitant \u00E0 2840 Rumst, Kloosterstraat 28;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0426624509",
        "name": "NOSHAQ",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "la soci\u00E9t\u00E9 anonyme NOSHAQ, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, Rue Lambert-Lombard 3, num\u00E9ro d\u0027entreprise 0426.624.509 (RPM Li\u00E8ge, division Li\u00E8ge), qui a d\u00E9clar\u00E9 de nommer en qualit\u00E9 de repr\u00E9sentant permanent, Madame TOUNSI Amel, habitant \u00E0 1090 Jette, Jean Gabinplein 1 A1;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DALTON Colin Clive",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Margarite Limited",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "la soci\u00E9t\u00E9 \u00E9trang\u00E8re Margarite Limited, ayant son si\u00E8ge \u00E0 Quorn, Leicestershire, LE12 8DX (Royaume-Uni), 78 Loughborough Road, qui sera repr\u00E9sent\u00E9e de fa\u00E7on permanente par Monsieur DALTON Colin Clive, habitant \u00E0 Ketteringham, WYMONDHAM, Norfolk, NR18 9RU (Royaume-Uni), The Lodge, High Street."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}
2019
02-09-2019 Incorporation of a new SNC Incorporation
Summary: oprichting
Technical details 
{
  "kind": "oprichting",
  "seat": "Boulevard Gustave-Kleyer 17, 4000 Li\u00E8ge",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "VAN ROMPAY Pieter",
        "niss": null,
        "address": "Lindenlaan 3, 2580 Putte"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "VAN ROMPAY Pieter",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "VAN ROMPAY Stijn",
        "niss": null,
        "address": "Vlieghavenlaan 24, 3140 Keerbergen"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "VAN ROMPAY Stijn",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "FOIDART Jean Michel Francine Charles Simonne Ren\u00E9",
        "niss": null,
        "address": "4870 Trooz, Rue Sur la Heid 3"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "FOIDART Jean Michel Francine Charles Simonne Ren\u00E9",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 600000,
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO Biologics",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2019-08-28",
  "post_incorporation_mandates": []
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Vervaardiging van overige farmaceutische producten21209
Primary activity highlighted.
Names & trade names
Legal nameFR EXO Biologics
Registered office
Boulevard de Patience et Beaujonc 3 bus 2
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 148 of 1,176 with filed accounts
Advanced Coatings & Construction Solutions BE 0434.800.025 · Liège
ARAPONICS BE 0890.381.113 · Liège
ARTIALIS BE 0830.584.472 · Liège
Centre Belge d'Etude et d'Expertise de l'Eau BE 0402.381.833 · Liège
CENTRE DE DEVELOPPEMENT DE L'IN VITRO BE 0429.047.925 · Liège
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative